According to Extension Toxicology Network in the U.S., "The oral median Lethal Dose or for atrazine is 3090 mg/kg in
rats, 1750 mg/kg in
mice, 750 mg/kg in
rabbits, and 1000 mg/kg in hamsters. The dermal LD50 in rabbits is 7500 mg/kg. The 1-hour inhalation LC50 is greater than 0.7 mg/L in rats. The 4-hour inhalation LC50 is 5.2 mg/L in rats." The
maximum contaminant level is 0.003 mg/L and the
reference dose is 0.035 mg/kg/day.
Cancer In 2025, IARC updated the classification of atrazine to be "probably carcinogenic to humans" (
Group 2A). A 2011 study that tracked 57,310 licensed American pesticide applicators over 13 years concluded that "there was no consistent evidence of an association between atrazine use and any cancer site".
General reproductive health Studies suggest it is an
endocrine disruptor, an agent that can alter the natural hormonal system. Some studies have been complicated by poor reproducibility conflicts of interest, and accusations of retribution. The U.S. EPA's Scientific Advisory Panel examined relevant studies and concluded in 2010, "atrazine does not adversely affect amphibian gonadal development based on a review of laboratory and field studies". It recommended proper study design for further investigation. As required by the EPA, two experiments were conducted under Good Laboratory Practices (GLP) and were inspected by EPA and German regulatory authorities, concluding 2009 that "long-term exposure of larval
X. laevis to atrazine at concentrations ranging from 0.01 to 100 μg/L does not affect growth, larval development, or sexual differentiation". Atrazine may affect reproduction of minnows. A 2011 review of the mammalian reproductive toxicology of atrazine jointly conducted by the
World Health Organization and the
Food and Agriculture Organization of the United Nations concluded that atrazine was not
teratogenic. Reproductive effects in rats and rabbits were only seen at doses that were toxic to the mother. Observed adverse effects in rats included
fetal resorption in rates (at doses ≥50 mg/kg per day), delays in sexual development in female rats (at doses ≥30 mg/kg per day), and decreased birth weight (at doses ≥3.6 mg/kg per day). A 2014 systematic review, funded by atrazine manufacturer Syngenta, assessed its relation to reproductive health problems. The authors concluded that the quality of most studies was poor and without good quality data, the results were difficult to assess, though it was noted that no single category of negative pregnancy outcome was found consistently across studies. The authors concluded that a causal link between atrazine and adverse pregnancy outcomes was not warranted due to the poor quality of the data and the lack of robust findings across studies. Syngenta was not involved in the design, collection, management, analysis, or interpretation of the data and did not participate in the preparation of the manuscript.
Aquatic impacts and regulation According to the U.S. EPA, the maximum allowable atrazine concentration in drinking water is 3 μg/L. This level was established in 2011 and remains in place in 2025. Because it is pervasive in
run-off, its impact on aquatic life has been scrutinized. A
Natural Resources Defense Council report from 2009 said that the EPA is ignoring atrazine contamination in surface and drinking water in the central United States. Atrazine has a negative impact on aquatic life. In 2010, the
Australian Pesticides and Veterinary Medicines Authority (APVMA) tentatively concluded that environmental atrazine "at existing levels of exposure" was not affecting amphibian populations in Australia consistent with the 2007 U.S. EPA findings. APVMA responded to Hayes' 2010 published paper, that his findings "do not provide sufficient evidence to justify a reconsideration of current regulations which are based on a very extensive dataset". ==Regulatory action==